The X-Change Corporation XCHC
In press release published yesterday, the company announced its plans to roll out its Phytiva products in S. California. The second announcement of its kind in the last week, we can see that XCHC is rigorously pursuing its quest to expand its recently acquired line.
DALLAS, Jan. 28, 2013 /PRNewswire via COMTEX/ — X-Change Corp. (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is extract-based Cosmeceutical and Nutraceuticals solutions through its Phytiva brand product line, announced today that it has been in discussions with California-based cannabis businesses for plans of a full rollout of Phytiva products to consumers in Southern California.The California legal cannabis market is estimated at $12 -$18 billion in total economic activity, supporting 60,000 to 110,000 jobs and $2.5 to $3.5 billion in legal, taxable wages. The cannabis industry is a much needed windfall for the State of California which is in economic distress. Further, the industry would generate additional income and business taxes for the state. California is one of the leading states for Medical Cannabis since first legalizing in mid 1990’s.
These inquiries came from conservative, well-managed firms that participate in full legal compliance through their dispensary licenses. They have physical locations in place that will allow X-Change Corporation to market its full line of Phytiva products.
You may have missed yesterday’s link to our short video presentation of XCHC, so click here and take a look.
- X-Change Corp In Discussions to Rollout Phytiva Products in China and Southeast Asia (Fri, Jan 25)
- X-Change Appoints Harvard Law Graduate Chad S. Johnson, Esq., to the Board of Directors, as Chief Operating Officer (COO) and General Counsel of the Corporation (Thu, Jan 24)
For more information, visit: http://www.phytiva.com
Therapeutic Solutions International, Inc. TSOI
A few weeks ago, we noticed TSOI coming off its 52-week low of .01. It was January 14th and 15th when we included it in our extended watchlist, and it was trading as low as .0151. Yesterday the stock managed to close at the high of day of .045, breaching its 20, 50 and 100DMA’s. That move represents a possible gain of 198% from our first mention just two weeks prior.
We would like to see support hold at .04, above the moving averages going forward in order for us to remain bullish on TSOI.
Keryx Biopharmaceuticals, Inc. KERX
Speaking of watchlist plays that have made their mark, KERX appeared in our extended watchlist on January 23rd. We’ve since watched it run from a low of 3.46, and we are now observing pre- market trading at 7.03, a gain of 103%
MYRY, IFLM, MILV, PLXT